Peripheral arterial disease (PAD) - A challenging manifestation of atherosclerosis
- PMID: 37031910
- DOI: 10.1016/j.ypmed.2023.107489
Peripheral arterial disease (PAD) - A challenging manifestation of atherosclerosis
Abstract
The diagnosis of peripheral arterial disease (PAD) is not always evident as symptoms and signs may show great variation. As all grades of PAD are linked to both an increased risk for cardiovascular complications and adverse limb events, awareness of the condition and knowledge about diagnostic measures, prevention and treatment is crucial. This article presents in a condensed form information on PAD and its management.
Keywords: Diagnostics; Epidemiology; Management; PAD; Pathophysiology; Symptoms.
Crown Copyright © 2023. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
The importance of early diagnosis and treatment in peripheral arterial disease: insights from the PARTNERS and REACH registries.Curr Vasc Pharmacol. 2010 May;8(3):293-300. doi: 10.2174/157016110791112304. Curr Vasc Pharmacol. 2010. PMID: 19758116 Review.
-
Screening for Peripheral Arterial Disease.Bol Asoc Med P R. 2015 Jul-Sep;107(3):95-7. Bol Asoc Med P R. 2015. PMID: 26742205 Review.
-
Patterns of disease distribution of lower extremity peripheral arterial disease.Angiology. 2015 Mar;66(3):211-8. doi: 10.1177/0003319714525831. Epub 2014 Mar 19. Angiology. 2015. PMID: 24650949 Review.
-
Epidemiology of Peripheral Artery Disease and Polyvascular Disease.Circ Res. 2021 Jun 11;128(12):1818-1832. doi: 10.1161/CIRCRESAHA.121.318535. Epub 2021 Jun 10. Circ Res. 2021. PMID: 34110907 Free PMC article.
-
Contemporary risk assessment and cardiovascular outcomes in peripheral arterial disease.Cardiovasc Hematol Disord Drug Targets. 2013 Dec;13(3):185-96. doi: 10.2174/1871529x1303140129154241. Cardiovasc Hematol Disord Drug Targets. 2013. PMID: 24479718 Review.
Cited by
-
Syndrome de l’artère poplitée piégée chez un homme de 20 ans.CMAJ. 2025 May 11;197(18):E514-E518. doi: 10.1503/cmaj.241083-f. CMAJ. 2025. PMID: 40355144 Free PMC article. French. No abstract available.
-
Comparisons of risk factors and outcomes between abdominal aortic aneurysm and peripheral arterial disease: a case-control study.Am J Med Open. 2025 Jan 14;13:100087. doi: 10.1016/j.ajmo.2025.100087. eCollection 2025 Jun. Am J Med Open. 2025. PMID: 39991140 Free PMC article.
-
Inhibition effect of copper-bearing metals on arterial neointimal hyperplasia via the AKT/Nrf2/ARE pathway in vitro and in vivo.Regen Biomater. 2024 Apr 16;11:rbae042. doi: 10.1093/rb/rbae042. eCollection 2024. Regen Biomater. 2024. PMID: 39027361 Free PMC article.
-
The Impact of Flavonoids and Omega-3 in Mitigating Frailty Syndrome to Improve Treatment Outcomes in Peripheral Artery Disease (PAD) Patients.Nutrients. 2025 Jul 12;17(14):2303. doi: 10.3390/nu17142303. Nutrients. 2025. PMID: 40732928 Free PMC article. Review.
-
Computational modeling of drug-eluting balloons in peripheral artery disease: Mechanisms, optimization, and translational insights.Comput Struct Biotechnol J. 2025 Aug 7;27:3640-3653. doi: 10.1016/j.csbj.2025.08.005. eCollection 2025. Comput Struct Biotechnol J. 2025. PMID: 40895288 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials